Quantitative Sensory Testing Predicts Pregabalin Efficacy in Painful Chronic Pancreatitis

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Olesen, Søren S ^a   Graversen, Carina ^a,b   Bouwense, Stefan A W ^c   van Goor, Harry ^c   Wilder Smith, Oliver H G ^c,d   Drewes, Asbjørn M ^a,d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREGABALIN;

ANALGESIA; ARTICLE; CHRONIC PAIN; CHRONIC PANCREATITIS; CONTROLLED STUDY; DERMATOME; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROSTIMULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROMODULATION; PAIN ASSESSMENT; PAIN THRESHOLD; PARALLEL DESIGN; PREDICTION; PRESSURE STIMULATION; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SENSORY SYSTEM PARAMETERS; SKIN STIMULATION; STIMULATION; SUPPORT VECTOR MACHINE; TETANIZATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; ANALGESICS; ELECTRIC STIMULATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PANCREATITIS, CHRONIC; PLACEBOS; PRESSURE; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINES; TREATMENT OUTCOME;

EID: 84874566533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057963     Document Type: Article

References (37)

1. Pasricha PJ, (2012) Unraveling the mystery of pain in chronic pancreatitis. Nature Reviews.Gastroenterology & Hepatology 9: 140-151.
2. Mullady DK, Yadav D, Amann ST, O'Connell MR, Barmada MM, et al. (2011) Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: A prospective cohort study. Gut 60: 77-84.
3. Gardner TB, Kennedy AT, Gelrud A, Banks PA, Vege SS, et al. (2010) Chronic pancreatitis and its effect on employment and health care experience: Results of a prospective american multicenter study. Pancreas 39: 498-501.
4. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y, (2012) Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 153: 1193-1198.
5. Edwards RR, Haythornthwaite JA, Tella P, Max MB, Raja S, (2006) Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology 104: 1243-1248.
6. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D, (2004) Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 62: 218-225.
7. Hansson P, Backonja M, Bouhassira D, (2007) Usefulness and limitations of quantitative sensory testing: Clinical and research application in neuropathic pain states. Pain 129: 256-259.
8. Arendt-Nielsen L, Laursen RJ, Drewes AM, (2000) Referred pain as an indicator for neural plasticity 7. Progress in Brain Research 129: 343-356.
9. Buscher HC, Wilder-Smith OH, van Goor H, (2006) Chronic pancreatitis patients show hyperalgesia of central origin: A pilot study. European Journal of Pain (London, England) 10: 363-370.
10. Pud D, Granovsky Y, Yarnitsky D, (2009) The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain 144: 16-19.
11. Olesen SS, Bouwense SA, Wilder-Smith OH, van Goor H, Drewes AM, (2011) Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 141: 536-543.
12. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U, (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 110: 628-638.
13. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC, (2008) Pregabalin for postherpetic neuralgia: Placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. The Journal of Pain: Official Journal of the American Pain Society 9: 1006-1017.
14. Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt MH, Hollmann MW, et al. (2008) Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 136: 150-157.
15. Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, et al. (2002) Inhibition of neuronal ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42: 229-236.
16. Houghton LA, Fell C, Whorwell PJ, Jones I, Sudworth DP, et al. (2007) Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 56: 1218-1225.
17. Olesen SS, Graversen C, Olesen AE, Frokjaer JB, Wilder-Smith O, et al. (2011) Randomised clinical trial: Pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis. Alimentary Pharmacology & Therapeutics 34: 878-887.
18. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, et al. (1994) The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 107: 1481-1487.
19. Bouwense SA, Buscher HC, van Goor H, Wilder-Smith OH, (2011) Has central sensitization become independent of nociceptive input in chronic pancreatitis patients who fail thoracoscopic splanchnicectomy? Regional Anesthesia and Pain Medicine 36: 531-536.
20. Vapnik VN, (1999) An overview of statistical learning theory. IEEE Transactions on Neural Networks/a Publication of the IEEE Neural Networks Council 10: 988-999.
21. Lee Y, (2010) Support vector machines for classification: A statistical portrait. Methods in Molecular Biology (Clifton, N.J.) 620: 347-368.
22. Rojas J, Fernandez I, Pastor JC, Garcia-Gutierrez MT, Sanabria RM, et al. (2009) Development of predictive models of proliferative vitreoretinopathy based on genetic variables: The retina 4 project. Investigative Ophthalmology & Visual Science 50: 2384-2390.
23. Pocock SJ, Hughes MD, Lee RJ, (1987) Statistical problems in the reporting of clinical trials. A survey of three medical journals. The New England Journal of Medicine 317: 426-432.
24. Altman DG, Gore SM, Gardner MJ, Pocock SJ, (1983) Statistical guidelines for contributors to medical journals. British Medical Journal (Clinical Research Ed.) 286: 1489-1493.
25. Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, et al. (2010) Clinical pharmacokinetics of pregabalin in healthy volunteers. Journal of Clinical Pharmacology 50: 941-950.
26. Olesen AE, Olofsen E, Olesen SS, Staahl C, Andresen T, et al. (2012) The absorption profile of pregabalin in chronic pancreatitis. Basic & Clinical Pharmacology & Toxicology 111: 385-390.
27. Olesen SS, van Goor H, Bouwense SA, Wilder-Smith OH, Drewes AM (2012) Reliability of static and dynamic quantitative sensory testing in patients with painful chronic pancreatitis. Regional Anesthesia and Pain Medicine.
28. Arendt-Nielsen L, Andresen T, Malver LP, Oksche A, Mansikka H, et al. (2011) A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: A human experimental study. The Clinical Journal of Pain.
29. Cathcart S, Winefield AH, Rolan P, Lushington K, (2009) Reliability of temporal summation and diffuse noxious inhibitory control. Pain Research & Management: The Journal of the Canadian Pain Society = Journal De La Societe Canadienne Pour Le Traitement De La Douleur 14: 433-438.
30. Olesen SS, Brock C, Krarup AL, Funch-Jensen P, Arendt-Nielsen L, et al. (2010) Descending inhibitory pain modulation is impaired in patients with chronic pancreatitis. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 8: 724-730.
31. Bouwense SA, Olesen SS, Drewes AM, Poley JW, van Goor H, et al. (2012) Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial. PloS One 7: e42096.
32. Dimcevski G, Sami SA, Funch-Jensen P, Le PD, Valeriani M, et al. (2007) Pain in chronic pancreatitis: The role of reorganization in the central nervous system. Gastroenterology 132: 1546-1556.
33. Chen AC, Dworkin SF, Haug J, Gehrig J, (1989) Human pain responsivity in a tonic pain model: Psychological determinants. Pain 37: 143-160.
34. Fehrenbacher JC, Taylor CP, Vasko MR, (2003) Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 105: 133-141.
35. Gottrup H, Juhl G, Kristensen AD, Lai R, Chizh BA, et al. (2004) Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 101: 1400-1408.
36. Fujisawa M, Shoji S, Ishibashi K, Clark GT, (1999) Pressure pain threshold with and without iontophoretic anesthesia of the masseter muscle in asymptomatic males. Journal of Orofacial Pain 13: 97-103.
37. McQuay HJ, Derry S, Eccleston C, Wiffen PJ, Andrew Moore R, (2012) Evidence for analgesic effect in acute pain- 50 years on. Pain 153: 1364-1367.